ALZpath Proprietary pTau217 Antibody Wins BioTech Breakthrough Award for 'Diagnostics Innovation of the Year' | ALZpath Transformative Antibody Recognized for Advancing Global Alzheimer's Disease Detection

ALZpath’s proprietary #pTau217 antibody has been named Diagnostics Innovation of the Year by the 2025 #BioTechBreakthroughAwards — recognizing its impact in advancing earlier, more accessible #AlzheimersDisease detection.

🔗Read more: alzpath.bio/alzpath-prop...